Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the six-month period from May 14, 2013, to October 31, 2013. The document serves as a Block Listing Six Monthly Return, detailing the status of various share option and savings-related share schemes. It does not contain general business operations updates or financial performance data.
Key Financial Metrics
The filing text does not provide values for revenue, profit, cash flow, margins, debt, or liquidity. The document is strictly limited to equity scheme administration data.
Material Changes in Equity Schemes
The filing reports activity across nine distinct share schemes. Key movements include:
- GlaxoSmithKline Share Option Plan (Ordinary Shares): Increased by 10,000,000 shares; 8,664,315 shares issued. Ending balance: 9,758,028.
- GlaxoSmithKline Share Option Plan (ADS): Increased by 10,000,000 shares; 9,784,992 shares issued. Ending balance: 8,875,532.
- GlaxoSmithKline Savings Related Share Option Scheme: No increase; 70,093 shares issued. Ending balance: 2,742,626.
- GlaxoSmithKline plc Sharesave plan 2012: Increased by 10,000 shares; 5,023 shares issued. Ending balance: 9,684.
- Other Schemes: The Glaxo Wellcome UK, Glaxo Wellcome International, Glaxo Wellcome 1999, and three SmithKline Beecham 1989 plans reported no increases and no issuances during the period, maintaining their previous balances.
Management Commentary and Unusual Items
The filing notes an administrative error in the previous period's return (November 1, 2012 - May 31, 2013) regarding the opening balances for the "GlaxoSmithKline Savings Related Share Option Scheme" and the "GlaxoSmithKline plc Sharesave plan 2012." The discrepancy was 289 shares for each scheme, which has been corrected in the opening balance of this return.
Investor Verification Checklist
- Verify the total number of shares available for issuance under the two primary GSK Share Option Plans (Ordinary and ADS) following the 10 million share increases.
- Confirm the administrative correction of 289 shares for the Savings Related and Sharesave plans against prior filings.
- Note that this filing contains no financial performance data; refer to Form 20-F or quarterly earnings releases for revenue and profit metrics.